TrialBMC psychiatry2026

Seizure adequacy and safety of remimazolam in electroconvulsive therapy for patients with psychiatric disorders: a double-blind randomized crossover trial.

Tianqi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.